Sabaa International Company for Pharmaceutical and Chemical Industry (EGX:SIPC)
Egypt flag Egypt · Delayed Price · Currency is EGP
3.640
-0.040 (-1.09%)
At close: Feb 2, 2026

EGX:SIPC Income Statement

Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
54.0722.7813.3118.245.4269.76
Revenue Growth (YoY)
247.49%71.17%-26.88%-59.93%-34.89%3.60%
Cost of Revenue
28.7319.943.5110.8926.6730.03
Gross Profit
25.342.849.87.3118.7539.73
Selling, General & Admin
6.276.296.485.729.8519.25
Other Operating Expenses
3.110.99-0.04---
Operating Expenses
15.8513.76.455.739.919.5
Operating Income
9.49-10.863.341.588.8520.23
Interest Expense
-2.24-1.2-1.05-1.07-0.65-0.66
Currency Exchange Gain (Loss)
0.69-8.66-0.620--
Other Non Operating Income (Expenses)
2.122.120.50.440.62-
Pretax Income
10.06-18.612.180.968.8119.56
Income Tax Expense
-3.77-0.571.020.942.034.42
Net Income
13.83-18.041.160.026.7815.14
Preferred Dividends & Other Adjustments
--0.1201.293.11
Net Income to Common
13.83-18.041.040.015.4912.04
Net Income Growth
--6280.77%-99.73%-55.22%76.28%
Shares Outstanding (Basic)
250250250250250-
Shares Outstanding (Diluted)
250250250250250-
EPS (Basic)
0.06-0.070.000.000.02-
EPS (Diluted)
0.06-0.070.000.000.02-
EPS Growth
--7075.86%-99.74%--
Free Cash Flow
-5.71-2.082.09-17.293.44-15.25
Free Cash Flow Per Share
-0.02-0.010.01-0.070.01-
Gross Margin
46.87%12.47%73.63%40.17%41.28%56.95%
Operating Margin
17.55%-47.68%25.13%8.70%19.48%29.00%
Profit Margin
25.58%-79.19%7.82%0.08%12.09%17.26%
Free Cash Flow Margin
-10.57%-9.14%15.72%-94.97%7.57%-21.86%
EBITDA
13.09-7.776.565.412.0622.6
EBITDA Margin
24.21%-34.10%49.31%29.68%26.55%32.40%
D&A For EBITDA
3.63.093.223.823.212.38
EBIT
9.49-10.863.341.588.8520.23
EBIT Margin
17.55%-47.68%25.13%8.70%19.48%29.00%
Effective Tax Rate
--46.88%98.11%23.04%22.60%
Advertising Expenses
-000.03--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.